Chapter 1

This is a listing of all citations in this chapter.

31

American Regent Inc., 2021. “Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure with Iron Deficiency (HEART-FID),” (ClinicalTrials.gov Identifier: NCT03037931), updated November 16, 2021.

32

National Institute of Allergy and Infectious Diseases (NIAID), “Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level,” (ClinicalTrials.gov Identifier: NCT03341273), updated August 24, 2021.

33

Priyanka Boghani, “Dr. Paul Offit: ‘A Choice Not to Get a Vaccine Is Not a Risk-Free Choice,’ Frontline,” Public Broadcasting Service, November 20, 2015

34

Priyanka Boghani, “Dr. Paul Offit: ‘A Choice Not to Get a Vaccine Is Not a Risk-Free Choice,’ Frontline,” Public Broadcasting Service, November 20, 2015.

35

The College of Physicians of Philadelphia, “Vaccines 101: Ethical Issues and Vaccines,” The College of Physicians of Philadelphia, accessed September 19, 2022.

36

The Cochrane Collaboration is an international network of researchers and health professionals headquartered in the UK and produces information for making healthcare decisions. They do not receive any commercial funding. Their mission is to be “an independent, diverse, global organization that collaborates to produce trusted synthesized evidence, make it accessible to all, and advocate for its use.” Accessed May 27, 2023.

37

Andrew Anglemyer et al., “Healthcare Outcomes Assessed with Observational Study Designs Compared with Those Assessed in Randomized Trials,” Cochrane Database of Systematic Reviews (2014). doi: 10.1002/14651858.MR000034.pub2.

38

Frank DeStefano et al., “Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-Matched Control Subjects: A Population-Based Study in Metropolitan Atlanta,” Pediatrics 113, no. 2 (2004): 259–266, doi:10.1542/peds.113.2.259.

39

Thomas Verstraeten et al., “Safety of Thimerosal-Containing Vaccines: A Two-Phased Study of Computerized Health Maintenance Organization Databases,” Pediatrics 112, no. 5 (2003): 1039–1048. doi:10.1542/peds.112.5.1039.

40

Cristofer S. Price et al., “Prenatal and Infant Exposure to Thimerosal from Vaccines and Immunoglobulins and Risk of Autism,” Pediatrics 126, no. 4 (2010): 656–664. doi:10.1542/peds.2010-0309.

41

Frank DeStefano et al., “Increasing Exposure to Antibody-Stimulating Proteins and Polysaccharides in Vaccines is Not Associated with Risk of Autism,” The Journal of Pediatrics 163, no. 2 (2013): 561–567. doi: 10.1016/j.jpeds.2013.02.001.

42

Priyanka Boghani, “Dr. Paul Offit: ‘A Choice Not to Get a Vaccine Is Not a Risk-Free Choice,’ Frontline,” Public Broadcasting Service, November 20, 2015.

43

Dan Olmsted, “The Age of Autism: The Amish Elephant,” UPI, October 29, 2005.

44

Holly A. Hill et al., “Vaccination Coverage Among Children Aged 19-35 Months – United States, 2017,” Morbidity Mortality Weekly Report 67, no. 40 (2018): 1123–1128. doi:10.15585/mmwr.mm6740a4.

45

“Amish in America, American Experience,” Public Broadcasting Service, accessed July 15, 2022.

46

Children’s Health Defense, “Vaxxed – Unvaxxed: Parts I-XII,” accessed on September 15, 2022.